Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 1
2014 1
2015 2
2016 8
2017 9
2018 5
2019 5
2020 1
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives.
França TT, Barreiros LA, Al-Ramadi BK, Ochs HD, Cabral-Marques O, Condino-Neto A. França TT, et al. Among authors: cabral marques o. Expert Rev Clin Immunol. 2019 May;15(5):529-540. doi: 10.1080/1744666X.2019.1573674. Epub 2019 Feb 18. Expert Rev Clin Immunol. 2019. PMID: 30681380 Review.
Mechanisms of Autoantibody-Induced Pathology.
Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, Komorowski L, Luo J, Cabral-Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F. Ludwig RJ, et al. Among authors: cabral marques o. Front Immunol. 2017 May 31;8:603. doi: 10.3389/fimmu.2017.00603. eCollection 2017. Front Immunol. 2017. PMID: 28620373 Free PMC article. Review.
Loss of balance in normal GPCR-mediated cell trafficking.
Cabral-Marques O, Carvalho-Marques AH, Schimke LF, Heidecke H, Riemekasten G. Cabral-Marques O, et al. Front Biosci (Landmark Ed). 2019 Jan 1;24:18-34. doi: 10.2741/4707. Front Biosci (Landmark Ed). 2019. PMID: 30468645 Free article. Review.
COVID-19 vaccinations: The unknowns, challenges, and hopes.
Mohamed K, Rzymski P, Islam MS, Makuku R, Mushtaq A, Khan A, Ivanovska M, Makka SA, Hashem F, Marquez L, Cseprekal O, Filgueiras IS, Fonseca DLM, Mickael E, Ling I, Arero AG, Cuschieri S, Minakova K, Rodríguez-Román E, Abarikwu SO, Faten AB, Grancini G, Cabral-Marques O, Rezaei N. Mohamed K, et al. Among authors: cabral marques o. J Med Virol. 2021 Nov 29. doi: 10.1002/jmv.27487. Online ahead of print. J Med Virol. 2021. PMID: 34845731 Review.
The clinical spectrum and immunopathological mechanisms underlying ZIKV-induced neurological manifestations.
Filgueiras IS, Torrentes de Carvalho A, Cunha DP, Mathias da Fonseca DL, El Khawanky N, Freire PP, Cabral-Miranda G, Schimke LF, Camara NOS, Ochs HD, Peron JPS, Cabral-Marques O, de Vasconcelos ZFM. Filgueiras IS, et al. Among authors: cabral marques o. PLoS Negl Trop Dis. 2021 Aug 5;15(8):e0009575. doi: 10.1371/journal.pntd.0009575. eCollection 2021 Aug. PLoS Negl Trop Dis. 2021. PMID: 34351896 Free PMC article. Review.
VLP-Based COVID-19 Vaccines: An Adaptable Technology against the Threat of New Variants.
Prates-Syed WA, Chaves LCS, Crema KP, Vuitika L, Lira A, Côrtes N, Kersten V, Guimarães FEG, Sadraeian M, Barroso da Silva FL, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Cabral-Miranda G. Prates-Syed WA, et al. Among authors: cabral marques o. Vaccines (Basel). 2021 Nov 30;9(12):1409. doi: 10.3390/vaccines9121409. Vaccines (Basel). 2021. PMID: 34960155 Free PMC article. Review.
Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.
Kaimala S, Al-Sbiei A, Cabral-Marques O, Fernandez-Cabezudo MJ, Al-Ramadi BK. Kaimala S, et al. Among authors: cabral marques o. Front Oncol. 2018 May 1;8:136. doi: 10.3389/fonc.2018.00136. eCollection 2018. Front Oncol. 2018. PMID: 29765907 Free PMC article.
40 results